A controlled trial of isoniazid in persons with anergy and human immunodeficiency virus infection who are at high risk for tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS. (Q45761546)
scientific article published in July 1997
Language:
Current Data About A controlled trial of isoniazid in persons with anergy and human immunodeficiency virus infection who are at high risk for tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS.
(P31) (Q13442814)
(P248)
(P698) 9233868
(P813) Friday, December 15, 2017
(P854) http://europepmc.org/abstract/MED/9233868

(P304) 315-320
(P248)
(P698) 9233868
(P813) Friday, December 15, 2017
(P854) http://europepmc.org/abstract/MED/9233868

(P407) (Q1860)

(P433) 5
(P248)
(P698) 9233868
(P813) Friday, December 15, 2017
(P854) http://europepmc.org/abstract/MED/9233868

(P478) 337
(P248)
(P698) 9233868
(P813) Friday, December 15, 2017
(P854) http://europepmc.org/abstract/MED/9233868

(P577) Tuesday, July 1, 1997
(P248)
(P698) 9233868
(P813) Friday, December 15, 2017
(P854) http://europepmc.org/abstract/MED/9233868

(P921) (Q12204)

(Q423169)

(P1433) (Q582728)
(P248)
(P698) 9233868
(P813) Friday, December 15, 2017
(P854) http://europepmc.org/abstract/MED/9233868

(P1476) "A controlled trial of isoniazid in persons with anergy and human immunodeficiency virus infection who are at high risk for tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS." (language: en)
(P248)
(P698) 9233868
(P813) Friday, December 15, 2017
(P854) http://europepmc.org/abstract/MED/9233868

(P2093) Gordin FM
(P1545) 1
(P248)
(P698) 9233868
(P813) Friday, December 15, 2017
(P854) http://europepmc.org/abstract/MED/9233868

Matts JP
(P1545) 2
(P248)
(P698) 9233868
(P813) Friday, December 15, 2017
(P854) http://europepmc.org/abstract/MED/9233868

Miller C
(P1545) 3
(P248)
(P698) 9233868
(P813) Friday, December 15, 2017
(P854) http://europepmc.org/abstract/MED/9233868

Brown LS
(P1545) 4
(P248)
(P698) 9233868
(P813) Friday, December 15, 2017
(P854) http://europepmc.org/abstract/MED/9233868

Hafner R
(P1545) 5
(P248)
(P698) 9233868
(P813) Friday, December 15, 2017
(P854) http://europepmc.org/abstract/MED/9233868

John SL
(P1545) 6
(P248)
(P698) 9233868
(P813) Friday, December 15, 2017
(P854) http://europepmc.org/abstract/MED/9233868

Klein M
(P1545) 7
(P248)
(P698) 9233868
(P813) Friday, December 15, 2017
(P854) http://europepmc.org/abstract/MED/9233868

Vaughn A
(P1545) 8
(P248)
(P698) 9233868
(P813) Friday, December 15, 2017
(P854) http://europepmc.org/abstract/MED/9233868

Besch CL
(P1545) 9
(P248)
(P698) 9233868
(P813) Friday, December 15, 2017
(P854) http://europepmc.org/abstract/MED/9233868

Perez G
(P1545) 10
(P248)
(P698) 9233868
(P813) Friday, December 15, 2017
(P854) http://europepmc.org/abstract/MED/9233868

Szabo S
(P1545) 11
(P248)
(P698) 9233868
(P813) Friday, December 15, 2017
(P854) http://europepmc.org/abstract/MED/9233868

El-Sadr W
(P1545) 12
(P248)
(P698) 9233868
(P813) Friday, December 15, 2017
(P854) http://europepmc.org/abstract/MED/9233868

other details
description scientific article published in July 1997

External Links
(P356) 10.1056/NEJM199707313370505
(P698) 9233868